A short at 17.40 to 16.57 with the necessary risk management will bring a 4.8%+ return
On 2/28/2024, TG Therapeutics (TGTX) reported a loss of $0.09 per share on revenue of $43.97 million for the fourth quarter ended December 2023. The consensus estimate was a loss of $0.12 per share on revenue of $40.06 million.
Its a point where it can go buy from, but its a weak price point at $17 - $18. it has to show me a reversal pattern to consider buying from those prices. The best situation is if the price decreases to around $13 - $14 to buy until $25 that's 80% growth.
TG Therapeutics (NASDAQ:TGTX) added ~21% pre-market Wednesday after the company posted solid topline and bottom-line beats with its Q3 2023 financials. The Morrisville, North Carolina-based biotech reported $165.8M in net revenue for the quarter, up from $94M in the prior-year period, exceeding the consensus by as much as $102.5M. A one-time payment of $140M from...
TGTX on pullback to the OB can benefit with a 4R is my thought. let me know what you think
Falling wedge within a larger broadening wedge. Daily hidden bullish divergence. Strong bull trend above the 150MA.
Top trading idea for next week(s)! NASDAQ:TGTX already proved itself with a strong performance YTD of 125% (and 580% in a year). The stock is in a clear stage 2 uptrend and is now consolidating in between the 21 day MA and 50 day EMA on lower volume (check weekly chart). Has the fundamentals. A few more days of tight consolidation or a quick retest of the 50...
Biotech stocks can make huge moves, and this one is no exception. TGTX more than doubled in a month and is showing no signs of slowing down. Slower-trending, blue chip stocks tend to ride their 50-day moving average (red line on chart) on the way up. Stronger stocks tend to hold their 21-day moving average (blue line). But with high-flying honey badger stocks...
We are moving up. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to....
TGTX is Bull and it is entering the Trend Channel. It made an Elliot Wave, and it is rebounding to the trend. Its growth will also be fueled by XBI which is also bullish.
TGTX made an Elliot Wave but it failed to continue the trend after the Correction Wave and it collapsed. However, The Elliot Impulse Wave did create potential for TGTX because it built up a good Trend Channel. To continue to grow, it would need to enter Trend Channel first and then stabilize within it. The green dotted line is where it needs to go. Note: This...
My favorite biotech... TGTX! Which way will it move?
Confluencing trend reversal signals as described in 'Price Action Breakdown'. I have yet to effectively apply the reading. Still trying to make sense of it. using it only when appropriate. that sort of thing.
Getting into long position with TGTX. Aslo suits for long term investment
i think TGTX has an FDA approval coming up and a great cup and handle it can break out of im excited to see the price action on this on be patient with the entry good luck! if anyone knows lmk when the FDA approval is
After failing to follow through on the 02/05 breakout, were now back at the 50ma with a gap fill along with decreasing volume. I think this is a hit or a miss, it'll most likely bounce strongly and make new highs or continue grinding down through the 50ma.
$TGTX Bull Flag on the weekly's. 2 FDA drug approval catalysts going forward.
Biotechnology is very important... however how far can things go up? And when will the market possibly change directions? Comments and Questions: These oscillators seem to suggest some changes around October of 2021? The patterns seem to be fairly stable when the price doesn't oscillate (differently from a trend) much for example before February of 2018? The...